• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.在肯尼亚和南非向用户群体推出基于 ARV 的预防措施时选择的重要性:一项定性研究。
J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19157. doi: 10.7448/IAS.17.3.19157. eCollection 2014.
2
Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment.南非豪登省男性、女性、少女及女性性工作者对基于抗逆转录病毒药物的艾滋病毒预防方法的偏好:一项离散选择实验方案
BMJ Open. 2016 Jun 27;6(6):e010682. doi: 10.1136/bmjopen-2015-010682.
3
Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.关于口服和阴道抗逆转录病毒药物用于 HIV 预防的观点:南非约翰内斯堡的 VOICE-C 定性研究。
J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19146. doi: 10.7448/IAS.17.3.19146. eCollection 2014.
4
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.城市南非异性恋男性对长效注射型 HIV 暴露前预防(PrEP)需求的决定因素。
BMC Public Health. 2019 Jul 24;19(1):996. doi: 10.1186/s12889-019-7276-1.
5
Communicating about microbicides with women in mind: tailoring messages for specific audiences.关注女性视角,宣传杀微生物剂:为特定受众定制信息。
J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19151. doi: 10.7448/IAS.17.3.19151. eCollection 2014.
6
Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.将暴露前预防措施纳入常规计划生育诊所提供服务:肯尼亚的一项可行性方案评估。
PLoS Med. 2019 Sep 3;16(9):e1002885. doi: 10.1371/journal.pmed.1002885. eCollection 2019 Sep.
7
Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.对 HIV 预防措施的不同偏好:南非多用途 HIV 预防产品的离散选择实验。
Med Decis Making. 2018 Jan;38(1):120-133. doi: 10.1177/0272989X17729376. Epub 2017 Sep 1.
8
Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.年轻女性对生物医学 HIV 预防措施的表述偏好:肯尼亚和南非的离散选择实验结果。
J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):394-403. doi: 10.1097/QAI.0000000000001945.
9
Women and ARV-based HIV prevention - challenges and opportunities.妇女与基于抗逆转录病毒药物的艾滋病预防:挑战与机遇。
J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19356. doi: 10.7448/IAS.17.3.19356. eCollection 2014.
10
"Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.一石二鸟——南非约翰内斯堡女性对双重预防丸的看法的定性研究。
BMC Womens Health. 2024 Aug 22;24(1):462. doi: 10.1186/s12905-024-03269-8.

引用本文的文献

1
User preferences on long-acting pre-exposure prophylaxis for HIV prevention in Eastern and Southern Africa: a scoping review.东非和南部非洲地区用户对长效暴露前预防艾滋病病毒的偏好:一项范围综述
BMC Public Health. 2025 Jul 3;25(1):2361. doi: 10.1186/s12889-025-23529-y.
2
Alcohol Use and the Pre-exposure Prophylaxis Continuum of Care Among Men in Rural South Africa: Results from a Longitudinal Study.南非农村地区男性的酒精使用与暴露前预防连续护理:一项纵向研究的结果
AIDS Behav. 2025 Apr 5. doi: 10.1007/s10461-025-04694-y.
3
High Preference for Injectable Pre-exposure Prophylaxis among Young Women in Kenya.肯尼亚年轻女性对注射用暴露前预防药物的高度偏好。
AIDS Behav. 2025 Mar 24. doi: 10.1007/s10461-025-04687-x.
4
Qualitative focus group discussions exploring PrEP method and service delivery preferences among female sex workers and their managers in four Zambian provinces.在赞比亚四个省份对女性性工作者及其管理者进行的定性焦点小组讨论,探讨了暴露前预防方法和服务提供偏好。
BMJ Public Health. 2024 Feb 22;2(1):e000483. doi: 10.1136/bmjph-2023-000483. eCollection 2024 Jun.
5
Cost thresholds for anticipated long-acting HIV pre-exposure prophylaxis products in Eastern and Southern Africa: a mathematical modelling study.东非和南部非洲预期长效艾滋病毒暴露前预防产品的成本阈值:一项数学建模研究。
J Int AIDS Soc. 2025 Feb;28(2):e26427. doi: 10.1002/jia2.26427.
6
Willingness to Use Long-Acting Injectable Pre-Exposure Prophylaxis among Adolescent Girls and Young Women in Kampala, Uganda.乌干达坎帕拉少女和年轻女性使用长效注射式暴露前预防药物的意愿
AIDS Behav. 2025 May;29(5):1458-1469. doi: 10.1007/s10461-025-04616-y. Epub 2025 Jan 30.
7
Barriers to PrEP use and adherence among adolescent girls and young women in Eastern, Southern, and Western Africa: a scoping review.东非、南非和西非青少年女孩和年轻女性中预防艾滋病病毒暴露前预防(PrEP)使用及依从性的障碍:一项范围综述
BMC Womens Health. 2024 Dec 26;24(1):665. doi: 10.1186/s12905-024-03516-y.
8
The effect of daily oral PrEP use during pregnancy on bone mineral density among adolescent girls and young women in Uganda.乌干达青春期女孩和年轻女性孕期每日口服暴露前预防用药对骨密度的影响。
Front Reprod Health. 2024 Jan 8;5:1240990. doi: 10.3389/frph.2023.1240990. eCollection 2023.
9
"Protected Means Armed": Perspectives on Pre-Exposure Prophylaxis (PrEP) Among Women Who Engage in Sex Work and Use Drugs in Kazakhstan.“受保护即武装”:哈萨克斯坦从事性工作和吸毒的女性对暴露前预防(PrEP)的看法。
AIDS Educ Prev. 2023 Oct;35(5):347-361. doi: 10.1521/aeap.2023.35.5.347.
10
Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.系统评价关于使用注射用暴露前预防措施预防 HIV 感染的价值观和偏好。
J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26107. doi: 10.1002/jia2.26107.

本文引用的文献

1
Use of modern contraception increases when more methods become available: analysis of evidence from 1982-2009.更多避孕方法的可及性提高了现代避孕措施的使用率:来自 1982-2009 年的证据分析。
Glob Health Sci Pract. 2013 Jul 26;1(2):203-12. doi: 10.9745/GHSP-D-13-00010. eCollection 2013 Aug.
2
How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa.我们真正能期待对新型艾滋病毒预防技术有多大需求?来自南非一项离散选择实验的结果。
PLoS One. 2013 Dec 30;8(12):e83193. doi: 10.1371/journal.pone.0083193. eCollection 2013.
3
High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.高危人群中 HIV 暴露前预防措施接受度高,但在坚持和使用方面存在挑战:肯尼亚一项间歇性和每日 PrEP Ⅰ期试验中的定性研究结果
AIDS Behav. 2013 Jul;17(6):2162-72. doi: 10.1007/s10461-012-0317-8.
4
Oral antiretroviral chemoprophylaxis: current status.口服抗逆转录病毒化学预防:现状。
Curr Opin HIV AIDS. 2012 Nov;7(6):514-9. doi: 10.1097/COH.0b013e3283582d30.
5
Preexposure prophylaxis for HIV infection among African women.预防非洲女性感染 HIV 的暴露前预防措施。
N Engl J Med. 2012 Aug 2;367(5):411-22. doi: 10.1056/NEJMoa1202614. Epub 2012 Jul 11.
6
Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.肯尼亚 HIV-1 血清不一致夫妇使用基于抗逆转录病毒的 HIV-1 预防策略的意愿。
J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):116-9. doi: 10.1097/QAI.0b013e31825da73f.
7
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention.解析 HIV 预防的暴露前预防试验结果为何出现分歧。
AIDS. 2012 Apr 24;26(7):F13-9. doi: 10.1097/QAD.0b013e3283522272.
8
Pre-exposure prophylaxis--one more tool for HIV prevention.暴露前预防——预防艾滋病病毒的又一手段。
Curr HIV Res. 2012 Mar;10(2):117-22. doi: 10.2174/157016212799937254.
9
What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.爱情与此有何关系?解释 HIV 血清不一致的夫妇坚持使用口服抗逆转录病毒暴露前预防的原因。
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):463-8. doi: 10.1097/QAI.0b013e31824a060b.
10
Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study.在 HIV 阴性的男同性恋和双性恋者中,艾滋病毒暴露前预防的性行为风险和可接受性:一项混合方法研究。
AIDS Patient Care STDS. 2012 Feb;26(2):87-94. doi: 10.1089/apc.2011.0283. Epub 2011 Dec 7.

在肯尼亚和南非向用户群体推出基于 ARV 的预防措施时选择的重要性:一项定性研究。

The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.

机构信息

Social and Behavioral Health Sciences, FHI 360, Durham, NC, USA;

Health Services Research, FHI 360, Durham, NC, USA.

出版信息

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19157. doi: 10.7448/IAS.17.3.19157. eCollection 2014.

DOI:10.7448/IAS.17.3.19157
PMID:25224616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4164014/
Abstract

INTRODUCTION

Stakeholders continue to discuss the appropriateness of antiretroviral-based pre-exposure prophylaxis (PrEP) for HIV prevention among sub-Saharan African and other women. In particular, women need formulations they can adhere to given that effectiveness has been found to correlate with adherence. Evidence from family planning shows that contraceptive use, continuation and adherence may be increased by expanding choices. To explore the potential role of choice in women's use of HIV prevention methods, we conducted a secondary analysis of research with female sex workers (FSWs) and men and women in serodiscordant couples (SDCs) in Kenya, and adolescent and young women in South Africa. Our objective here is to present their interest in and preferences for PrEP formulations - pills, gel and injectable.

METHODS

In this qualitative study, in Kenya we conducted three focus groups with FSWs, and three with SDCs. In South Africa, we conducted two focus groups with adolescent girls, and two with young women. All focus groups were audio-recorded, transcribed and translated into English as needed. We structurally and thematically coded transcripts using a codebook and QSR NVivo 9.0; generated code reports; and conducted inductive thematic analysis to identify major trends and themes.

RESULTS

All groups expressed strong interest in PrEP products. In Kenya, FSWs said the products might help them earn more money, because they would feel safer accepting more clients or having sex without condoms for a higher price. SDCs said the products might replace condoms and reanimate couples' sex lives. Most sex workers and SDCs preferred an injectable because it would last longer, required little intervention and was private. In South Africa, adolescent girls believed it would be possible to obtain the products more privately than condoms. Young women were excited about PrEP but concerned about interactions with alcohol and drug use, which often precede sex. Adolescents did not prefer a particular formulation but noted benefits and limitations of each; young women's preferences also varied.

CONCLUSIONS

The circumstances and preferences of sub-Saharan African women are likely to vary within and across groups and to change over time, highlighting the importance of choice in HIV prevention methods.

摘要

引言

利益相关者继续讨论在撒哈拉以南非洲和其他地区的女性中使用基于抗逆转录病毒的暴露前预防(PrEP)进行 HIV 预防的适当性。特别是,鉴于有效性与依从性相关,女性需要她们能够坚持的制剂。计划生育方面的证据表明,扩大选择范围可能会增加避孕措施的使用、持续使用和依从性。为了探索选择在女性使用 HIV 预防方法中的潜在作用,我们对肯尼亚的女性性工作者(FSW)以及血清不一致夫妇(SDC)中的男性和女性和南非的青少年和年轻女性进行了一项二次分析。我们的目标是介绍她们对 PrEP 制剂(药丸、凝胶和注射剂)的兴趣和偏好。

方法

在这项定性研究中,我们在肯尼亚进行了三项 FSW 焦点小组和三项 SDC 焦点小组的研究。在南非,我们进行了两项青春期少女焦点小组和两项年轻女性焦点小组的研究。所有焦点小组都进行了录音,需要时转录并翻译成英文。我们使用代码簿和 QSR NVivo 9.0 对转录本进行了结构性和主题性编码;生成代码报告;并进行了归纳主题分析,以确定主要趋势和主题。

结果

所有群体都对 PrEP 产品表示出浓厚的兴趣。在肯尼亚,FSW 表示这些产品可能会帮助她们赚更多的钱,因为她们会感到更安全,可以接受更多的客户或不使用安全套进行更高价格的性行为。SDC 表示,这些产品可能会取代避孕套并重新激发夫妻的性生活。大多数性工作者和 SDC 更喜欢注射剂,因为它的作用时间更长,需要的干预较少,而且比较私密。在南非,青少年女孩认为可以比避孕套更私密地获得这些产品。年轻女性对 PrEP 感到兴奋,但担心与酒精和药物的相互作用,这些通常发生在性行为之前。青少年不喜欢特定的制剂,但注意到每种制剂的优缺点;年轻女性的偏好也各不相同。

结论

撒哈拉以南非洲女性的情况和偏好可能在群体内部和群体之间有所不同,并随时间而变化,这突显了在 HIV 预防方法中选择的重要性。